Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy

Human Gene Therapy

Volumn 17, Issue 2, 2006, Pages 193-205

  Thirion, Christian ^a,b,g   Lochmüller, Hanns ^a   Ruzsics, Zsolt ^c   Boelhauve, Marc ^c   König, Cornelia ^a   Thedieck, Cornelia ^a   Kutik, Stephan ^a   Geiger, Christiane ^d   Kochanek, Stefan ^b   Volpers, Christoph ^e   Burgert, Hans Gerhard ^f  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e UNIVERSITY OF COLOGNE   (Germany)

^f UNIVERSITY OF WARWICK   (United Kingdom)

^g Division of Gene Therapy   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ARGINYLGLYCYLASPARTIC ACID; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; ENHANCED GREEN FLUORESCENT PROTEIN; HEPARIN; SIALIDASE; VIRUS RECEPTOR; WHEAT GERM AGGLUTININ;

ADENOVIRUS 19; ANIMAL CELL; ARTICLE; CELL BASED GENE THERAPY; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; MYOBLAST; MYOTUBE; NONHUMAN; RAT; RECEPTOR AFFINITY; SKELETAL MUSCLE; SPECIES DIFFERENCE; VIRUS GENOME;

ADENOVIRUSES, HUMAN; ANIMALS; CELLS, CULTURED; EPITOPES; FLOW CYTOMETRY; GENE THERAPY; GENETIC VECTORS; HEPARITIN SULFATE; HUMANS; MICE; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOBLASTS; N-ACETYLNEURAMINIC ACID; RATS; RECEPTORS, VIRUS; SPECIES SPECIFICITY; TRANSDUCTION, GENETIC; TROPISM; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALIA; COXSACKIEVIRUS; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS TYPE 19A; PRIMATES; TRITICUM AESTIVUM;

EID: 32944459691     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.17.193     Document Type: Article

References (52)

1. ACSADI, G., JANI, A., HUARD, J., BLASCHUK, K., MASSIE, B., HOLLAND, P., LOCHMÜLLER, H., and KARPATI, G. (1994). Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants. Gene Ther. 1, 338-340.
2. ARNBERG, N., EDLUND, K., KIDD, A.H., and WADELL, G. (2000a). Adenovirus type 37 uses sialic acid as a cellular receptor. J. Virol. 74, 42-48.
3. v integrins. J. Virol. 74, 7691-7693.
4. BERGELSON, J.M., CUNNINGHAM, J.A., DROGUETT, G., KURT-JONES, E.A., KRITHIVAS, A., HONG, J.S., HORWITZ, M.S., CROWELL, R.L., and FINBERG, R.W. (1997). Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320-1323.
5. BIERMANN, V.C., VOLPERS, C., HUSSMANN, S., STOCK, A., KEWES, H., SCHIEDNER, G., HERRMANN, A., and KOCHANEK, S. (2001). Targeting of high-capacity adenoviral vectors. Hum. Gene Ther. 12, 1757-1769.
6. BILBAO, R., SRINIVASAN, S., REAY, D., GOLDBERG, L., HUGHES, T., ROELVINK, P.W., EINFELD, D.A., WICKHAM, T.J., and CLEMENS, P.R. (2003). Binding of adenoviral fiber knob to the coxsackievirus-adenovirus receptor is crucial for transduction of fetal muscle. Hum. Gene Ther. 14, 645-649.
7. BLUM, H., BEIER, H., and GROSS, H.J. (1987). Improved silver staining of plant proteins, RNA, and DNA in polyacrylamide gels. Electrophoresis 8, 93-99.
8. BLUSCH, J.H., DERYCKERE, F., WINDHEIM, M., RUZSICS, Z., ARNBERG, N., ADRIAN, T., and BURGERT, H.G. (2002). The novel early region 3 protein E3/49K is specifically expressed by adenoviruses of subgenus D: Implications for epidemic keratoconjunctivitis and adenovirus evolution. Virology 296, 94-106.
9. CHEN, P., KOVESDI, I., and BRUDER, J.T. (2000). Effective repeated administration with adenovirus vectors to the muscle. Gene Ther. 7, 587-595.
10. COHEN, C.J., XIANG, Z.Q., GAO, G.P., ERTL, H.C., WILSON, J.M., and BERGELSON, J.M. (2002). Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor. J. Gen. Virol. 83, 151-155.
11. DECHECCHI, M.C., TAMANINI, A., BONIZZATO, A., and GABRINI, G. (2000). Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology 268, 382-390.
12. DECHECCHI, M.C., MELOTTI, P., BONIZZATO, A., SANTACATTERIANA, M., CHILOSI, M., and GABRINI, G. (2001). Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J. Virol. 75, 8772-8780.
13. DE JONG, J.C., WERMENBOL, A.C., VERWEIJ-UIJTERWAAL, M.W., SLATERUS, K.W., WERTHEIM-VAN DILLEN, P., VAN DOORNUM, G.J.J., KHOO, S.H., and HIERHOLZER, J.C. (1999). Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J. Clin. Microbiol. 37, 3940-3945.
14. DENBY, L., WORK, L.M., GRAHAM, D., HSU, C., VON SEGGERN, D.J., NICKLIN, S.A., and BAKER, A.H. (2004). Adenoviral serotype 5 vectors pseudotyped with fibers from subgroup D show modified tropism in vitro and in vivo. Hum. Gene Ther. 15, 1054-1064.
15. FEERO, W.G., ROSENBLATT, J.D., HUARD, J., WATKINS, S.C., EPPERLY, M., CLEMENS, P.R., KOCHANEK, S., GLORIOSO, J.C., PARTRIDGE, T.A., and HOFFMAN, E.P. (1997). Viral gene delivery to skeletal muscle: Insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors. Hum. Gene Ther. 8, 371-380.
16. GAGGAR, A., SHAYAKHMETOV, D.M., and LIEBER, A. (2003). CD46 is a cellular receptor for group B adenoviruses. Nat. Med. 9, 1408-1412.
17. GORZIGLIA, M.I., LAPCEVICH, C., ROY, S., KANG, Q., KADAN, M., WU, V., PECHAN, P., and KALEKO, M. (1999). Generation of an adenovirus vector lacking E1, E2a, E3, and all of E4 except open reading frame 3. J. Virol. 73, 6048-6055.
18. HARVEY, B.G., HACKETT, N.R., EL-SAWY, T., ROSENGART, T.K., HIRSCHOWITZ, E.A., LIEBERMAN, M.D., LESSER, M.L., and CRYSTAL, R.G. (1999). Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs. J. Virol. 73, 6729-6742.
19. HAVENGA, M.J., LEMCKERT, A.A., OPHORST, O.J., VAN MEIJER, M., GERMERAAD, W.T., GRIMBERGEN, J., VAN DEN DOEL, M.A., VOGELS, R., VAN DEUTEKOM, J., JANSON, A.A., DE BRUIJN, J.D., UYDEHAAG, F., QUAX, P.H., LOGTENBERG, T., MEHTALI, M., and BOUT, A. (2002). Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease. J. Virol. 76, 4612-4620.
20. HITT, M., BETT, A., PREVEC, L., and GRAHAM, F.L. (1998). Construction and propagation of human adenovirus vectors. In Cell Biology: A Laboratory Handbook. J.E. Celis, ed. (Academic Press, San Diego, CA) Vol. 1, pp. 500-512.
21. HONG, S.S., KARAYAN, L, TOURNIER, J., CURIEL, D.T., and BOULANGER, P.A. (1997). Adenovirus type 5 fiber knob binds to MHC class I α2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J. 16, 2294-2306.
22. HUARD, J., LOCHMÜLLER, H., ACSADI, G., JANI, A., HOLLAND, P., GUERIN, C., MASSIE, B., and KARPATI, G. (1995). Differential short-term transduction efficiency of adult versus newborn mouse tissues by adenoviral recombinants. Exp. Mol. Pathol. 62, 131-143.
23. INOUE, N., IKAWA, M., NAKANISHI, T., MATSUMOTO, M., NOMURA, M., SEYA, T., and OKABE, M. (2003). Disruption of mouse CD46 causes an accelerated spontaneous acrosome reaction in sperm. Mol. Cell. Biol. 23, 2614-2622.
24. KNAAN-SHANZER, S., VAN DER VELDE, I., HAVENGA, M.J., LEMCKERT, A.A., DE VRIES, A.A., and VALERIO, D. (2001). Highly efficient targeted transduction of undifferentiated human hematopoietic cells by adenoviral vectors displaying fiber knobs of sub-group B. Hum. Gene Ther. 12, 1989-2005.
25. LUSKY, M., GRAVE, L., DIETERLE, A., DREYER, D., CHRIST, M., ZILLER, C., FÜRSTENBERGER, P., KINTZ, I., HADJI, D.A., PAVIRANI, A., and MEHTALI, M. (1999). Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: Requirement of E4 ORF3. J. Virol. 73, 8308-8319.
26. MA, L., BLUYSSEN, H.A., DE RAEYMAEKER, M., LAURYSENS, V., VAN DER BEEK, N., PAVLISKA, H., VAN ZONNEVELD, A.J., TOMME, P., and VAN ES, H.H., (2001). Rapid determination of adenoviral vector titers by quantitative real-time PCR. J. Virol. Methods 93, 181-188.
27. MASTRANGELI, A., HARVEY, B.C., YAO, J. WOLFF, G., KOVESDI, I., CRYSTAL, R.G., and FALCK-PEDERSEN, E. (1996). "Sero-switch" adenovirus-mediated in vivo gene transfer: Circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype. Hum. Gene Ther. 7, 79-87.
28. MITTEREDER, N., MARCH, K.L., and TRAPNELL, B.C. (1996). Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70, 7498-7509.
29. MORRAL, N., O'NEAL, W., RICE, K., LELAND, M., KAPLAN, J., PIEDRA, P.A., ZHOU, H., PARKS, R.J., VELJI, R., AGUILAR-CORDOVA, E., WADSWORTH, S., GRAHAM, F.L., KOCHANEK, S., CAREY, K.D., and BEAUDET, A.L. (1999). Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc. Natl. Acad. Sci. U.S.A. 96, 12816-12821.
30. NALBANTOGLU, J., PARI, G., KARPATI, G., and HOLLAND, P.C. (1999). Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells. Hum. Gene Ther. 10, 1009-1019.
31. NEMEROW, G.R. (2000). Cell receptors involved in adenovirus entry. Virology 274, 1-4.
32. NICKLIN, S.A., WU, E., NEMEROW, G.R., and BAKER, A.H. (2005). The influence of adenovirus fiber structure and function on vector development for gene therapy. Mol. Ther. 12, 384-393.
33. PARKS, R.J., EVELEGH, C., and GRAHAM, F. (1999). Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration. Gene Ther. 6, 1565-1573.
34. REA, D., HAVENGA, M.J., VAN DEN ASSEM, M., SUTMULLER, R.P., LEMCKERT, A., HOEBEN, R.C., BOUT, A., MELIEF, C.J., and OFFRINGA, R. (2001). Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells. J. Immunol. 166, 5236-5244.
35. ROELVINK, P.W., LIZONOVA, A., LEE, J.G., LI, Y., BERGELSON, J.M., FINBERG, R.W., BROUGH, D.E., KOVESDI, I., and WICKHAM, T.J. (1998). The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J. Virol. 72, 7909-7915.
36. RUZSICS, Z., WAGNER, M., OSTERLEHNER, A., COOK, J., KOSZINOWSKI, U., and BURGERT, H.-G. (2006). A novel adenovirus vector based on Ad19a generated by a versatile method for cloning and efficient genetic manipulation of any adenovirus. (manuscript in preparation).
37. SCHIEDNER, G., HERTEL, S., and KOCHANEK, S. (2000). Efficient transformation of primary human amniocytes by El functions of Ad5: Generation of new cell lines for adenoviral vector production. Hum. Gene Ther. 11, 2105-2116.
38. SEGERMAN, A., ATKINSON, J.P., MARTTILA, M., DENNERQUIST, V., WADELL, G., and ARNBERG, N. (2003). Adenovirus type 11 uses CD46 as a cellular receptor. J. Virol. 77, 9183-9191.
39. STONE, D., NI, S., LI, Z.Y., GAGGAR, A., DIPAOLO, N., FENG, Q., SANDIG, V., and LIEBER, A. (2005). Development and assessment of human adenovirus type 11 as a gene transfer vector. J. Virol. 79, 5090-5104.
40. SUZUKI, Y., ITO, T., SUZUKI, T., HOLLAND, R.E. Jr., CHAMBERS, T.M., KISO, M., ISHIDA, H., and KAWAOKA, Y. (2000). Sialic acid species as a determinant of the host range of influenza A viruses. J. Virol. 74, 11825-11831.
41. TAN, P.K., MICHOU, A.I., BERGELSON, J.M., and COTTON, M. (2001). Defining CAR as a cellular receptor for the avian adenovirus CELO using a genetic analysis of the two viral fibre proteins. J. Gen. Virol. 82, 1465-1472.
42. TOMKO, R.P., XU, R., and PHILIPSON, L. (1997). HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. U.S.A. 94, 3352-3356.
43. VOGELS, R., ZUIJDGEEST, D., VAN RIJNSOEVER, R., HARTKOORN, E., DAMEN, I, DE BETHUNE, M.P., KOSTENSE, S., PENDERS, G., HELMUS, N., KOUDSTAAL, W., CECCHINI, M., WETTERWALD, A., SPRANGERS, M., LEMCKERT, A., OPHORST, O., KOEL, B., VAN MEERENDONK, M., QUAX, P., PANITTI, L., GRIMBERGEN, J., BOUT, A., GOUDSMIT, J., and HAVENGA, M. (2003). Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: Efficient human cell infection and bypass of preexisting adenovirus immunity. J. Virol. 77, 8263-8271.
44. VOLPERS, C., THIRION, C, BIERMANN, V., HUSSMANN, S., KEWES, H., DUNANT, P., VON DER MARK, H., HERRMANN, A., KOCHANEK, S., and LOCHMÜLLER, H. (2003). Antibody-mediated targeting of an adenovirus vector modified to contain a synthetic immunoglobulin G-binding domain in the capsid. J. Virol. 77, 2093-2104.
45. WADELL, G. (1984). Molecular epidemiology of human adenoviruses. Curr. Top. Microbiol. Immunol. 110, 191-220.
46. WADELL, G., and DE JONG, J.C. (1980). Restriction endonucleases in identification of a genome type of adenovirus 19 associated with keratoconjuncttvitts. Infect. Immun. 27, 292-296.
47. WALSH, F.S., and RITTER, M.A. (1981). Surface antigen differentiation during human myogenesis in culture. Nature 289, 60-64.
48. 5 promote adenovirus internal-ization but not virus attachment. Cell 73, 309-319.
49. WINDHEIM, M., and BURGERT, H.G. (2002). Characterization of E3/49K, a novel, highly glycosylated E3 protein of the epidemic keratoconjunctivitis- causing adenovirus type 19a. J. Virol. 76, 755-766.
50. WU, E., FERNANDEZ, J., FLECK, S.K., VON SEGGERN, D.J., HUANG, S., and NEMEROW, G.R. (2001). A 50-kDa membrane protein mediates sialic acid-independent binding and infection of conjunctival cells by adenovirus type 37. Virology 279, 78-89.
51. WU, E., TRAUGER, S.A., PACHE, L., MÜLLEN, T.M., VON SEGGERN, D.J., SIUZDAK, G., and NEMEROW, G.R. (2004). Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. J. Virol. 78, 3897-3905.
52. YOSHIDA, K., HIGASHINO, F., and FUJINAGA K. (1995). Transcriptional regulation of the adenovirus E1A gene. Curr. Top. Microbiol. Immunol. 199, 113-130.